Praluent® (Alirocumab) Pregnancy Exposure Registry: An OTIS Pregnancy Surveillance Study
Condition(s):HypercholesterolemiaLast Updated:November 23, 2020Terminated
Hide Studies Not Open or Pending
Condition(s):HypercholesterolemiaLast Updated:November 23, 2020Terminated
Condition(s):SepsisLast Updated:November 7, 2023Recruiting
Condition(s):Atherosclerosis; HyperlipidemiaLast Updated:April 26, 2019Unknown status
Condition(s):Heterozygous Familial Hypercholesterolemia; Non-familial HypercholesterolemiaLast Updated:June 15, 2021Terminated
Condition(s):Myocardial Infarction; HypercholesterolemiaLast Updated:September 6, 2019Completed
Condition(s):Hemodialysis; Peritoneal Dialysis; Hypercholesterolemia; Atherosclerotic DiseaseLast Updated:February 12, 2020Unknown status
Condition(s):Saphenous Vein Graft AtherosclerosisLast Updated:September 16, 2021Terminated
Condition(s):Atherosclerosis; Coronary Heart DiseaseLast Updated:November 7, 2018Completed
Condition(s):Hypercholesterolemia; Acute Coronary SyndromeLast Updated:September 9, 2019Completed
Condition(s):Peripheral Arterial DiseaseLast Updated:May 10, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.